Jolanda Howe's most recent trade in Mirum Pharmaceuticals Inc was a trade of 1,041 Restricted Stock Units done . Disclosure was reported to the exchange on July 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 1,041 | 0 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2025 | 1,041 | 3,467 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 48.25 per share. | 01 Jul 2025 | 564 | 2,903 (0%) | 0% | 48.3 | 27,213 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 49.08 per share. | 01 Jul 2025 | 477 | 2,426 (0%) | 0% | 49.1 | 23,411 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 44.45 per share. | 18 Mar 2025 | 2,415 | 2,426 (0%) | 0% | 44.4 | 107,343 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 52,900 | 0 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 15 Mar 2025 | 52,900 | 59,547 (0%) | 0% | 2.9 | 155,526 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 44.33 per share. | 15 Mar 2025 | 50,111 | 9,436 (0%) | 0% | 44.3 | 2,221,626 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 5,315 | 9,547 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 5,315 | 2,658 | - | - | Performance Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 44.21 per share. | 15 Mar 2025 | 2,900 | 6,647 (0%) | 0% | 44.2 | 128,221 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 44.75 per share. | 15 Mar 2025 | 2,789 | 6,647 (0%) | 0% | 44.7 | 124,802 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 44.36 per share. | 15 Mar 2025 | 1,806 | 4,841 (0%) | 0% | 44.4 | 80,113 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 1,772 | 5,296 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2025 | 1,772 | 1,771 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 48.22 per share. | 31 Jan 2025 | 1,064 | 4,232 (0%) | 0% | 48.2 | 51,309 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 1,500 | 4,426 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2025 | 1,500 | 3,000 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 47.92 per share. | 23 Jan 2025 | 902 | 3,524 (0%) | 0% | 47.9 | 43,228 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 18,500 | 18,500 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 7,973 | 7,973 | - | - | Performance Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 4,625 | 4,625 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2025 | 1,250 | 3,676 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2025 | 1,250 | 0 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 42.81 per share. | 06 Jan 2025 | 750 | 2,926 (0%) | 0% | 42.8 | 32,111 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 14 Nov 2024 | 2,500 | 4,926 (0%) | 0% | 2.9 | 7,350 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Nov 2024 | 2,500 | 52,900 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 47.10 per share. | 14 Nov 2024 | 2,500 | 2,426 (0%) | 0% | 47.1 | 117,752 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 1,042 | 2,801 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 1,042 | 1,041 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 34.00 per share. | 01 Jul 2024 | 375 | 2,426 (0%) | 0% | 34 | 12,750 | Common Stock |
| Mirum Pharmaceuticals Inc | Howe Jolanda | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 1,772 | 2,494 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jan 2024 | 1,772 | 3,543 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Howe Jolanda | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 26.19 per share. | 31 Jan 2024 | 735 | 1,759 (0%) | 0% | 26.2 | 19,251 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 18,000 | 18,000 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 4,500 | 4,500 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2024 | 1,250 | 1,250 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Howe Jolanda | SVP, GLOBAL CONTROLLER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2024 | 1,250 | 1,250 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale of securities on an exchange or to another person at price $ 28.04 per share. | 06 Jan 2024 | 528 | 722 (0%) | 0% | 28.0 | 14,803 | Common Stock |
| Mirum Pharmaceuticals Inc | Howe Jolanda | SVP, Global Controller | Sale of securities on an exchange or to another person at price $ 32.40 per share. | 05 Dec 2023 | 2,500 | 0 (0%) | 0% | 32.4 | 81,000 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.94 per share. | 05 Dec 2023 | 2,500 | 2,500 (0%) | 0% | 2.9 | 7,350 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 2,500 | 55,400 | - | - | Stock Option (right to buy) | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, Global Controller | Sale of securities on an exchange or to another person at price $ 26.23 per share. | 25 Aug 2023 | 3,459 | 0 (0%) | 0% | 26.2 | 90,743 | Common Stock |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 1,563 | 3,332 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 1,563 | 0 | - | - | Performance Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 1,042 | 4,374 (0%) | 0% | - | Common Stock | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, Global Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2023 | 1,042 | 2,083 | - | - | Restricted Stock Units | |
| Mirum Pharmaceuticals Inc | Jolanda Howe | SVP, Global Controller | Sale of securities on an exchange or to another person at price $ 25.65 per share. | 30 Jun 2023 | 915 | 3,459 (0%) | 0% | 25.6 | 23,467 | Common Stock |